Lipella Pharmaceuticals Inc. financial data

Symbol
LIPO on Nasdaq
Industry
Pharmaceutical Preparations
Location
400 N Lexington St, Ste Ll103, Pittsburgh, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 569 %
Debt-to-equity 21.9 %
Return On Equity -172 % -34.9%
Return On Assets -141 %
Operating Margin -839 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8M shares +39.4%
Common Stock, Shares, Outstanding 7.61M shares +32.4%
Entity Public Float 9.61M USD
Common Stock, Value, Issued 761 USD +32.6%
Weighted Average Number of Shares Outstanding, Basic 7.61M shares +32.4%
Weighted Average Number of Shares Outstanding, Diluted 7.61M shares +32.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 507K USD +27.9%
Research and Development Expense 2.79M USD -3.08%
General and Administrative Expense 1.97M USD +60.7%
Operating Income (Loss) -4.26M USD -14.1%
Nonoperating Income (Expense) 114K USD +140%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.14M USD -12.4%
Net Income (Loss) Attributable to Parent -4.14M USD -12.4%
Earnings Per Share, Basic -0.59 USD/shares +16.9%
Earnings Per Share, Diluted -0.59 USD/shares +16.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.19M USD -61.9%
Accounts Receivable, after Allowance for Credit Loss, Current 35.3K USD +26%
Assets, Current 2.08M USD -38.2%
Property, Plant and Equipment, Net 11.3K USD
Operating Lease, Right-of-Use Asset 92K USD -24.9%
Assets 2.18M USD -37.4%
Accounts Payable, Current 178K USD +709%
Accrued Liabilities, Current 127K USD -8.44%
Liabilities, Current 480K USD +60.7%
Operating Lease, Liability, Noncurrent 24K USD -70.4%
Liabilities 480K USD +31.9%
Retained Earnings (Accumulated Deficit) -12.5M USD -49.8%
Stockholders' Equity Attributable to Parent 1.7M USD -45.5%
Liabilities and Equity 2.18M USD -37.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.39M USD -28.8%
Net Cash Provided by (Used in) Financing Activities 200K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.61M shares +32.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.19M USD -61.9%
Deferred Tax Assets, Valuation Allowance 2.86M USD +25.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 2.86M USD +25.4%
Operating Lease, Liability 23.8K USD +45.1%
Operating Lease, Liability, Current 93.7K USD +54.1%
Deferred Tax Assets, Operating Loss Carryforwards 1.16M USD -15.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 14.2M USD +23.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 72 USD
Operating Leases, Future Minimum Payments Due 97K USD -27.9%
Interest Expense 17.2K USD +233%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%